CAH
63
3
ROP
38
-4
ESS
40
-5
NWSA
64
-15
CNX
49
3
DHR
66
2
AN
50
7
EMN
56
-2
ZION
71
2
GM
85
2
FFIV
47
-3
ETR
47
-2
AIG
77
2
NSC
48
-11
BIIB
50
4
BAX
38
-12
XYL
33
6
EFX
54
2
UHS
55
3
WAT
49
2
CAH
63
3
ROP
38
-4
ESS
40
-5
NWSA
64
-15
CNX
49
3
DHR
66
2
AN
50
7
EMN
56
-2
ZION
71
2
GM
85
2
FFIV
47
-3
ETR
47
-2
AIG
77
2
NSC
48
-11
BIIB
50
4
BAX
38
-12
XYL
33
6
EFX
54
2
UHS
55
3
WAT
49
2
Financhill
Back

Coca-Cola FEMSA SAB de CV Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
57

KOF
Coca-Cola FEMSA SAB de CV

Last Price:
$95.05
Seasonality Move:
3.06%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
57
Coca-Cola FEMSA SAB de CV (KOF) is a Buy

Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?

  • The current Coca-Cola FEMSA SAB de CV [KOF] share price is $94.96. The Score for KOF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • KOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KOF Stock Price Chart

What is Coca-Cola FEMSA SAB de CV's stock price today?

  • The Coca-Cola FEMSA SAB de CV share price today is $94.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOF is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

KOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.61 Buy
Relative Strength Index (14 RSI): 67.53 Buy
Chaikin Money Flow: 172912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.49 - 92.51) Buy
Bollinger Bands (100): (83.03 - 89.31) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

KOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 90.59 Buy
50-day SMA: 88.06 Buy
200-day SMA: 89.46 Buy
8-day EMA: 92.77 Buy
20-day EMA: 91.19 Buy
50-day EMA: 88.99 Buy
200-day EMA: 87.84 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Coca-Cola FEMSA SAB de CV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):